p16INK4a Antibody (C-term E119) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P42771 |
---|---|
Clone Names | 80722075 |
Gene ID | 1029 |
---|---|
Other Names | Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3, Cyclin-dependent kinase 4 inhibitor A, CDK4I, Multiple tumor suppressor 1, MTS-1, p16-INK4a, p16-INK4, p16INK4A, CDKN2A, CDKN2, MTS1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | CDKN2A (HGNC:1787) |
---|---|
Synonyms | CDKN2, MTS1 |
Function | Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein. |
Cellular Location | Cytoplasm. Nucleus |
Tissue Location | Widely expressed but not detected in brain or skeletal muscle. Isoform 3 is pancreas-specific |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a protein involved in peripheral nervemyelin upkeep. The encoded protein contains 2 PDZ domains whichwere named after PSD95 (post synaptic density protein), DlgA(Drosophila disc large tumor suppressor), and ZO1 (a mammaliantight junction protein). Two alternatively spliced transcriptvariants have been described for this gene which encode differentprotein isoforms and which are targeted differently in the Schwanncell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy,type 4F and Dejerine-Sottas neuropathy.
References
Benson, B., et al. Laryngoscope 120(2):291-296(2010)Kabzinska, D., et al. Med Wieku Rozwoj 13(2):146-153(2009)Auer-Grumbach, M., et al. Neuropediatrics 39(1):33-38(2008)Wu, C., et al. Proteomics 7(11):1775-1785(2007)Olsen, J.V., et al. Cell 127(3):635-648(2006)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.